Search Orphan Drug Designations and Approvals
-
Generic Name: | glucagon |
---|---|
Date Designated: | 12/05/2012 |
Orphan Designation: | Prevention of hypoglycemia in the congenital hyperinsulinism population |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Biodel, Inc. 100 Saw Mill Road Danbury, Connecticut 06810 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-